Search

everythinglearnresearchcommunity

for

Search:↓

USPlus PRO saw palmetto extract improves urinary symptoms and is safe for men.

Clofazimine may be effective for treating ashy dermatosis.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

Licorice can effectively treat stomach ulcers and may work as well as or better than some standard drugs.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Acitretin effectively treats severe hypertrophic lichen planus.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Combining ciclosporin and simvastatin can cause severe kidney damage.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Acarbose may improve PCOS symptoms and fertility, but more research is needed.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Oral Janus kinase inhibitors may be an effective treatment option for lichen planopilaris with some risk of increased cholesterol and liver enzyme levels.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.